These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 1541679

  • 1. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.
    Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC.
    J Clin Invest; 1992 Mar; 89(3):883-91. PubMed ID: 1541679
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor.
    Vargas SJ, Naprta A, Glaccum M, Lee SK, Kalinowski J, Lorenzo JA.
    J Bone Miner Res; 1996 Nov; 11(11):1736-44. PubMed ID: 8915781
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dexamethasone regulates IL-1 beta and TNF-alpha-induced interleukin-8 production in human bone marrow stromal and osteoblast-like cells.
    Chaudhary LR, Avioli LV.
    Calcif Tissue Int; 1994 Jul; 55(1):16-20. PubMed ID: 7922784
    [Abstract] [Full Text] [Related]

  • 7. Involvement of different second messengers in parathyroid hormone- and interleukin-1-induced interleukin-6 and interleukin-11 production in human bone marrow stromal cells.
    Kim GS, Kim CH, Choi CS, Park JY, Lee KU.
    J Bone Miner Res; 1997 Jun; 12(6):896-902. PubMed ID: 9169347
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro.
    Qu Q, Härkönen PL, Mönkkönen J, Väänänen HK.
    Bone; 1999 Aug; 25(2):211-5. PubMed ID: 10456387
    [Abstract] [Full Text] [Related]

  • 10. IL-6 mediates the effects of IL-1 or TNF, but not PTHrP or 1,25(OH)2D3, on osteoclast-like cell formation in normal human bone marrow cultures.
    Devlin RD, Reddy SV, Savino R, Ciliberto G, Roodman GD.
    J Bone Miner Res; 1998 Mar; 13(3):393-9. PubMed ID: 9525339
    [Abstract] [Full Text] [Related]

  • 11. Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy.
    Vargas SJ, Naprta A, Lee SK, Kalinowski J, Kawaguchi H, Pilbeam CC, Raisz LG, Lorenzo JA.
    J Bone Miner Res; 1996 Dec; 11(12):1926-34. PubMed ID: 8970895
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [Abstract] [Full Text] [Related]

  • 15. Effects of medroxyprogesterone acetate and beta-estradiol on interleukin-6 production from osteoblasts and bone marrow macrophages of Wistar rats of different ages.
    Futamura Y.
    J Toxicol Sci; 1995 May; 20(2):155-60. PubMed ID: 7473894
    [Abstract] [Full Text] [Related]

  • 16. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.
    Derigs HG, Reifel-Miller A, Kaushansky K, Hromas RA, Boswell HS.
    Exp Hematol; 1994 Aug; 22(9):924-32. PubMed ID: 8062890
    [Abstract] [Full Text] [Related]

  • 17. Alendronate and etidronate do not regulate interleukin 6 and 11 synthesis in normal human osteoblasts in culture.
    Engel E, Serrano S, Mariñoso ML, Lloreta J, Ulloa F, Nogués X, Diez-Pérez A, Carbonell J.
    Calcif Tissue Int; 2003 Mar; 72(3):228-35. PubMed ID: 12522661
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
    Saleh H, Eeles D, Hodge JM, Nicholson GC, Gu R, Pompolo S, Gillespie MT, Quinn JM.
    Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of interleukin-6 production by either calcitonin gene-related peptide or parathyroid hormone in two phenotypically distinct bone marrow-derived murine stromal cell lines.
    Sakagami Y, Girasole G, Yu XP, Boswell HS, Manolagas SC.
    J Bone Miner Res; 1993 Jul; 8(7):811-6. PubMed ID: 8394639
    [Abstract] [Full Text] [Related]

  • 20. The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line.
    Hofbauer LC, Ten RM, Khosla S.
    J Bone Miner Res; 1999 Aug; 14(8):1330-7. PubMed ID: 10457265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.